World news, news around town, tech update 3
Ad
Monday, 11 September 2017
Regeneron, Sanofi asthma drug data fails to excite investors
PARIS (Reuters) - Shares of Regeneron Inc and Sanofi SA slid on Monday after late-stage trial data for their asthma drug, dupilumab, fell short of investor expectations.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment